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Ultrasound in combination with microbubbles has recently been considered by gene delivery scientists to be an
interesting approach to enhance gene transfer into cells. Its low toxicity and simplicity to apply in vivo without major
complications make this technology (sonoporation) especially attractive. Sonoporation of DNA has been evaluated
in vivo by the injection of free plasmid DNA (pDNA) together with microbubbles (as used in diagnostic imaging)
in the bloodstream. However, the in vivo gene-transfer efficiency in these experiments remained rather low. Both the
enzymatic degradation of the injected pDNA as well as the low pDNA concentration in the neighborhood of sonoporated
cell membranes may explain this low efficiency. Therefore, we developed polymer-coated microbubbles that can bind
and protect the pDNA. Coating albumin-shelled microbubbles with poly(allylamine hydrochloride) (PAH) makes the
surface charge of the microbubbles positive without drastically affecting the size distribution of the microbubbles,
thereby not affecting the ultrasound responsiveness and injectability. The cationic coating allowed both to bind up
to 0.1 pg of DNA per microbubble as well as to protect the bound DNA against nucleases. Finally, the PAH coating
significantly increased the lifetime of the microbubbles (half-life  7 h), making them more convenient for in vivo
applications because more microbubbles are expected to reach the target organ. Binding and nuclease protection of
DNA by polymer-coated diagnostic microbubbles has, to our knowledge, never been demonstrated. We conclude that
these LbL-coated microbubbles might be significant in the further development of ultrasound-mediated gene delivery.
1. Introduction
Gene therapy was put forward in the late 1980s as the most
promising therapy for genetic diseases. However, gene therapy
is currently caught in a bottleneck because of the lack of efficient
and safe gene carriers. DNA molecules are large, negatively
charged molecules and have major difficulties in entering the
cell or cell nucleus. On top, DNA becomes rapidly degraded by
extra- and intracellular nucleases.1 Therefore, suitable DNA
delivery systems are under development. The first system makes
use of replication-deficient viruses that accommodate the
therapeutic DNA in their genome.1 These viral gene carriers
transfect very efficiently because they have an ingenious system
for the nuclear delivery of exogenous DNA. However, viral gene
carriers have some important disadvantages: they often provoke
an immune response and severe inflammation reactions.2
Additionally, the risk for insertional mutagenesis and the size
limitation of the DNA that they can accommodate are other
drawbacks of viral gene carriers.1 Therefore, nonviral transfection
systems based on cationic lipids or cationic polymers have gained
more and more attention.1 Although nonviral carriers may be
safer and cheaper, they have, especially in vivo, a much lower
transfection efficiency than viral gene carriers.
As outlined above, the in vivo application of viral and nonviral
DNA delivery systems is currently hampered by safety concerns
and low efficiency, respectively. To overcome the limitations of
nonviral gene therapy, ultrasound energy, alone or in combination
with gas-filled microbubbles, has recently been proposed to
enhance the intracellular delivery of DNA, siRNA, and
proteins.3-12 Because ultrasound energy in combination with
gas-filled microbubbles has been used for several years in medical
imaging, it can be considered to be very safe.13 The mechanism
by which ultrasound mediates intracellular drug delivery has
been ascribed as cavitation, which is the alternate growing and
shrinking of gas-filled microbubbles as a result of the high- and
low-pressure waves generated by ultrasound energy. Finally,
these “cavitating” (oscillating) microbubbles implode. The
cavitation and especially the implosion of the microbubbles
generate local shock waves and microjets that can temporarily
perforate the cell membrane, allowing macromolecules to enter
the cells.14-18 This ultrasound-assisted delivery of macromol-
ecules, often called sonoporation, has been proved to be effective
both in vitro and in vivo.3-12 However, a major limitation of the
currently available microbubbles is that they have a short lifetime
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and neither bind nor protect the therapeutic DNA against
nucleases. Binding of the DNA on the microbubbles will ensure
that the DNA is present at the site of cell membrane poration,
enhancing the chance that the DNA is dragged inside the cell
or even inside the nucleus by the generated microjets.
The aim of this work is to develop ultrasound-responsive
microbubbles that (a) can bind the DNA, (b) protect the DNA
against nucleases, and (c) remain stable for several hours.
Therefore, we coated, to our knowledge for the first time,
perfluorcarbon gas-filled microbubbles with a cationic polymer
via the layer-by-layer (LbL) technique.19 We characterized the
physical properties, ultrasound responsiveness, DNA binding,
and DNA protection toward nucleases of this new type of
microbubble.
2. Materials and Methods
2.1. Preparation of Microbubbles and PAH-Coated Mi-
crobubbles. Microbubbles were prepared following the procedure
developed by Porter et al.20 Briefly, one part of a 5% bovine serum
albumin (Sigma Aldrich, St Louis, MO) solution in HEPES buffer
(20 mM, pH 7.4) was mixed with two parts of a 5% dextrose (Sigma
Aldrich, St Louis, MO) solution in HEPES buffer. Subsequently,
the mixture was drawn into a 30 mL syringe and blended with 10
mL of perfluorobutane (MW 238 g/mol, F2 chemicals, Preston,
Lancashire, U.K.) through a three-way valve. After mixing by hand,
the solution was sonicated with a 20 kHz probe (Branson 250 sonifier,
Branson Ultrasonics Corp., Danbury, CT). Following sonication,
the microbubbles were centrifuged at 118g for 1 min. The subnatants
were discarded, and the microbubbles were washed three times with
sterile HEPES buffer. Finally, the microbubbles were suspended in
5 mL of sterile HEPES buffer.
The PAH-coated microbubbles were prepared by the layer-by-
layer (LbL) coating of the microbubbles obtained above. Five
milliliters of a microbubble dispersion was incubated with 5 mL of
a poly(allylamine hydrochloride) (PAH, MW 70 000 g/mol, Sigma-
Aldrich) solution (2 mg/mL, HEPES buffer). Subsequently, the PAH
was removed by washing (three times) the microbubbles with sterile
HEPES buffer. Therefore, after each wash step the microbubbles
were centrifuged at 118g for 1 min. Finally, the LbL-coated
microbubbles were suspended in 5 mL of sterile HEPES buffer.
2.2. Characterization of the Microbubbles. The concentration
of the microbubble dispersions was determined immediately after
their preparation with the aid of a Burker chamber and a light
microscope. The concentrations of the uncoated and coated mi-
crobubble dispersions were 9.57 ( 0.65  108 and 1.99 ( 0.10 
108 microbubbles/mL, respectively. To visualize the microbubbles,
they were brought into a í-slide VI flow chamber (Ibidi Integrated
BioDagnostics, Mu¨nchen, Germany) and studied via light (Nikon
TS100-F, Melville, NY) or confocal laser scanning microscopy
(CLSM) using a 40 lens. The size distribution of the microbubbles
was determined within 10 min after preparation by laser diffraction
(Mastersizer S, Malvern, Worcestershire, U.K.). The zeta potential
of the microbubbles was measured by particle electrophoresis
(Zetasizer 2000, Malvern, Worcestershire, U.K.). All the experiments
were performed on microbubbles dispersed in HEPES buffer (20
mM, pH 7.4).
2.3. Plasmid DNA Preparation. The plasmid DNA (pDNA;
pGL3, Promega, Leiden, The Netherlands) used in this study
contained as a reporter gene luciferase from Photinus pyralis under
the control of a simian virus 40 promotor. After amplification of the
pDNA in Escherichia coli, the pDNA was extracted and purified
from the bacterial cells using the Qiagen giga kit (Valencia, CA).
The pDNA concentration was set at 1.0 mg/mL HEPES buffer
assuming that the absorption at 260 nm of a 50 íg/mL DNA solution
equals 1. The pDNA showed a high purity because the ratio of the
absorptions at 260 and 280 nm was between 1.8 and 2.0.
2.4. Fluorescent Labeling of Albumin, PAH, and pDNA. Bovine
serum albumin (BSA, Sigma-Aldrich) was labeled with fluoresceine
isothiocyanate (FITC; Sigma-Aldrich) by vigorous mixing of 60
mL of FITC solution (0.2 mg/mL 0.1 M borate buffer at pH 8.5)
with 60 mL of BSA (5 mg/mL 0.1 M borate buffer at pH 8.5). The
labeling of PAH with rhodamine isothiocyanate (RITC) occurred in
a similar way. Twelve milligrams of RITC and 300 mg of PAH were
separately dissolved in 60 mL of borate buffer (0.1 M, pH 8.5) and
subsequently mixed under vigorous stirring. After overnight incuba-
tion, the reaction mixtures were dialyzed (MW cutoff of the membrane
was 25 kDa) against pure water for several days. Finally, the dialyzed
FITC-BSA and RITC-PAH were freeze dried, and the resulting
fluffy solids were stored at 4 °C.
Intercalating dyes YOYO-1 and TOTO-3 were used to label the
pDNA. Therefore, 111 íg of pDNA was mixed with 57 íL of a
1/100 diluted YOYO-1 or TOTO-3 solution (Molecular Probes,
Eugene, OR) and diluted in TE buffer (10 mM tris-HCl; 1 mM
EDTA; pH 7.4) until a final pDNA concentration of 1 mg/mL was
obtained. The dye/base pair ratio was 1:30 for both the YOYO-1
and TOTO-3 labeled pDNA. For the FCS measurements, the pDNA
was labeled with cy-5, using the Mirus labeling kit (Mirus Bio
Corporation, Madison, WI). The dye/base pair ratio was 1:2.
2.5. Confocal Laser Scanning Microscopy. The microbubbles,
put in í-slide VI-flow chambers, were visualized by a confocal laser
scanning microscope (CLSM, BioRad MRC 1024, Hemel Hempstadt,
U.K.) equipped with a krypton-argon laser and a dichroic mirror
that reflects the laser light in a 40 objective. The 488 nm line of
this laser was used to excite YOYO-1 and FITC, and the 568 nm
line was used to excite RITC. To ensure a proper spectral separation,
appropriate emission filters were used before the green and red
detector.
2.6. Electron Microscopy. Five microliters of a coated mi-
crobubble dispersion was applied on a silicon wafer and air dried.
The remains of the microbubbles were then examined with a scanning
electron microscope (Quanta 200 FEG, FEI Company, Hillsboro,
Oregon).
2.7. PicoGreen Assay and Fluorescence Fluctuation Spec-
troscopy. To determine the maximal pDNA loading capacity of the
microbubbles, we mixed 150 íL of the uncoated or coated
microbubble dispersions with increasing amounts of pDNA. After
10 min of incubation, the microbubbles (with pDNA) were
centrifuged at 118g, and the concentration of unbound pDNA in the
subnatants was determined using PicoGreen (Invitrogen, Merelbeke,
Belgium) and fluorescence correlation spectroscopy (FCS).
For the PicoGreen assay, 50 íL of the subnatants was incubated
with 1 mL of diluted (200-fold in TE buffer) PicoGreen reagent for
5 min, and subsequently the fluorescence was determined (ìexcitation)
480 nm and ìemission ) 520 nm).
We also determined the maximal pDNA loading capacity in another
way, making use of fluorescence fluctuation spectroscopy (FFS) to
measure the fluorescence of the unbound pDNA in the subnatants.
FFS monitors the fluorescence fluctuations in the excitation volume
of the microscope. The fluorescence signal is fluctuating because
of the diffusion of fluorescent molecules in and out of the excitation
volume. From the fluorescence fluctuations, an autocorrelation curve
can be derived that allows one to calculate both the diffusion
coefficient of the fluorescent molecules as well as the number of
fluorescent molecules in the excitation volume.21 Details of the FFS
setup used are explained in our earlier reports.22 For these experiments,
Cy5-labeled pDNA was used, and samples were excited with 6%
laser intensity (647 nm). First, a diluted solution of Cy5-pDNA was
measured. Afterwards, 50 íL of a coated bubble suspension was
incubated with 2 íg of pDNA. After 5 min of incubation, the sample
was diluted to the same Cy5-pDNA concentration, and the amount
of free pDNA was determined via FCS.
2.8. Ultrasound Responsiveness of the Microbubbles. The
ultrasound responsiveness of pDNA-loaded, PAH-coated mi-
(19) Decher, G. Science 1997, 277, 1232.
(20) Porter, T. R.; Iversen, P. L.; Li, S.; Xie, F. J. Ultrasound Med. 1996, 15,
577.
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crobubbles was determined by comparing their (number) concentra-
tion before and after exposure to ultrasound. pDNA-loaded
microbubbles were prepared by mixing 100 íL of a PAH-coated
microbubble dispersion with 2 íg of pDNA. After 10 min of
incubation, the concentration of the pDNA-loaded microbubbles
was determined in a Burker chamber. Subsequently, the pDNA-
loaded microbubbles were sonicated (1 MHz, 1 W/cm2; 50% duty
cycle) for 30 s using a Sonitron 2000 (RichMar, Inola, Oklahoma)
and again counted in a Burker chamber.
2.9. Gel Electrophoresis to Evaluate the Stability of Mi-
crobubble-Bound pDNA to rhDNase I. To determine whether the
microbubbles were able to protect the pDNA against rhDNase I
(Pulmozyme, Roche, Belgium), gel electrophoresis experiments were
performed. Two micrograms of pDNA was mixed with 50 íL of
a PAH-coated microbubble dispersion. After 5 min of incubation,
the pDNA/microbubble mixtures were diluted in HEPES buffer
supplied with 110 mM potassium acetate and 2 mM magnesium
acetate (pH 7.4), which is necessary to activate the rhDNase I.
Subsequently, rhDNase I was incubated with the pDNA/microbubbles
mixtures for 15 min at room temperature. The rhDNase I activity
in the microbubble dispersions was 200 U/L. Microbubble dispersions
“incubated with inhibited rhDNase I” received 8 íL of Na2EDTA
(50 mM) before the addition of the rhDNase I to the pDNA/
microbubble mixtures. Na2EDTA inhibits rhDNase I by complexing
the divalent cations, which are required for activating rhDNase I.
Other samples were supplemented with Na2EDTA after incubation
with rhDNase I.
After the incubation period with rhDNase I, the pDNA was released
from the microbubbles to investigate whether it survived the exposure
to rhDNase I. Therefore, NaCl was added to the pDNA/microbubbles
dispersions at a final concentration of 5 M. Subsequently, the pDNA/
microbubbles dispersions were centrifuged for 1 min at 118g. Fifty
microliters of the subnatants was mixed with 10 íL of a 30% glycerol
solution and loaded onto a 1.5% agarose gel prepared in TBE (10.8
g/L tris base, 5.5 g/L boric acid, and 0.58 g/L EDTA). The samples
were subjected to electrophoresis at 100 V for 60-90 min, and the
pDNA was visualized by ethidium bromide (0.5 íg/mL) staining
prior to UV photography.
3. Results and Discussion
3.1. Preparation and Characterization of Uncoated and
PAH-Coated Microbubbles. After the preparation of perfluo-
rocarbon microbubbles stabilized with (FITC-labeled) albumin,
CLSM experiments revealed the existence of micrometer-sized
spherical structures covered with green-labeled albumin (Figure
1) that floated atop the liquid. Because the size of the microbubbles
determines their ability to serve as cavitation nuclei, we subs-
equently studied the size distribution of freshly made mi-
crobubbles by laser diffraction.23 Most of the albumin-stabilized
microbubbles (about 90%) were between 1 and 5 ím in diameter
(Figure 2), which is a size known to favor cavitation upon exposure
to clinically used ultrasound frequencies (such as 1 MHz).23
The albumin chains, which cover the gaseous cores, stabilize
the microbubbles because they reduce the diffusion of the
perfluorocarbon gas out of the microbubbles in the surrounding
water. The shell-forming properties of albumin most likely
originate from its amphiphilic nature. Indeed, one can expect
that the hydrophobic regions of albumin have an affinity for the
perfluorocarbon gas, whereas its negatively charged hydrophilic
parts protrude into the aqueous phase. The presence of negative
charges at the surface of the albumin-stabilized microbubbles
was indeed confirmed from zeta potential (œ) measurements:
the average œ equalled -45 mV (Figure 3).
One can expect that the negative charges at the microbubbles’
surface would enable them to be coated with cationic polymers.
Therefore, we tried to apply a positively charged layer around
the albumin shell using PAH, a polycation that is widely used
in the LbL coating of planar substrates and colloidal tem-
plates.24-26 Figure 4 shows CLSM images of microbubbles
prepared with (nonfluorescently labeled) albumin and coated
with RITC-labeled PAH. Clearly, the PAH chains cover the
outer surface of the microbubbles and are not incorporated into
the perfluorocarbon gas core. Also, after the PAH coating, the
zeta potential of the microbubbles became positive (15 mV;
Figure 3), which further confirms the presence of PAH at the
(23) Unger, E. C.; Porter, T.; Culp, W.; Labell, R.; Matsunaga, T.; Zutshi, R.
AdV. Drug DeliVery ReV. 2004, 56, 1291.
Figure 1. Confocal fluorescence microscopy image of perfluoro-
carbon microbubbles stabilized with FITC-labeled albumin. De-
pending on the position of the confocal plane in the microbubbles,
we observed fluorescent rings (confocal plane in the middle of the
microbubbles) or filled circles (confocal plane at the top or bottom
of the microbubbles).
Figure 2. Size distribution of uncoated and PAH-coated albumin/
perfluorocarbon microbubbles as measured by laser diffraction. The
y axis shows to what extent a certain class of microbubbles is present,
normalized to the most abundant fraction of microbubbles (y ) 1).
Data are the means of three independent measurements.
Figure 3. Zeta potential of uncoated microbubbles (A), uncoated
microbubbles (50 íL) incubated with 1 íg of pDNA (B), PAH-
coated microbubbles (C), and PAH-coated bubbles (50 íL) incubated
with 1 íg of pDNA (D). The data are the means of three independent
measurements.
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surface of the microbubbles. Apart from a slightly elevated
fraction in the 5-20 ím range, which is probably due to the
aggregation of smaller microbubbles after coating, the PAH
coating changed the size distribution of the microbubbles only
moderately (Figure 2). In the remainder of this article, we use
the terms “uncoated: and “PAH-coated” microbubbles to refer
to albumin/perfluorocarbon microbubbles without and with a
PAH coating, respectively.
3.2. Stability of Uncoated and PAH-Coated Microbubbles.
It is well known that the lifetime of air-filled albumin-stabilized
microbubbles is very short because the air diffuses rapidly out
of the microbubbles.27 The use of perfluorocarbon gas, which
has a lower water solubility than air, effectively delays gas
diffusion.28 Nevertheless, their lifetime remains very short.
Coating microbubbles with PAH should offer a solution to this
problem because polyelectrolyte multilayers have been reported
to prevent or drastically decrease gas diffusion.29
Therefore, we evaluated the stability of the microbubbles at
room temperature by following the concentration of the mi-
crobubbles as a function of time. Figure 5A shows the percentage
of remaining uncoated and PAH-coated microbubbles as a
function of time. Uncoated microbubbles seem to destabilize
very rapidly: after 75 min, 50% of the uncoated microbubbles
have already disappeared. In contrast, PAH-coated microbubbles
clearly existed for much longer times: half of the PAH-coated
microbubbles had disappeared after 6 h.
3.3. DNA Binding Properties of the Microbubbles. The
pDNA binding properties of the microbubbles were first evaluated
by CSLM. To enable the visualization of the binding of pDNA
to the microbubbles, YOYO-1-labeled pDNA (green) and RITC-
labeled PAH (red) were used. Uncoated and PAH-coated albumin
microbubbles were incubated with pDNA for 2 min, transferred
to a í-slide VI flow chamber, and studied via CLSM. Figure 6
shows the results. Clearly, the green-labeled pDNA does not
bind to the uncoated albumin microbubbles but remains in solution
(Figure 6A). However, the green-labeled pDNA does bind to the
RITC-PAH-coated microbubbles (Figure 6B) because yellow
rings are present around the microbubbles, indicating the co-
Figure 4. Confocal fluorescence microscopy image (A) and
transmission image (B) of PAH-coated microbubbles made with
unlabeled albumin and RITC-labeled PAH.
Figure 5. (A) Stability of uncoated and PAH-coated microbubbles. The concentration of the microbubbles was measured as a function of
time and normalized to the concentration just after preparation. The dispersions were placed at room temperature under continuous stirring
at 750 rpm, and the concentration of microbubbles was determined microscopically using a Burker chamber. (B) Light microscopy images
of a destabilizing PAH-coated microbubble. The inset is an SEM image of the remaining polymer coating. Gradual shrinking was also observed
on uncoated microbubbles, although it occurred faster.
Figure 6. (A) Confocal fluorescence images of uncoated mi-
crobubbles (50 íL) incubated with 1 íg of YOYO-1-labeled pDNA,
(B) RITC-labeled PAH-coated microbubbles (50 íL) incubated with
2.6 íg of YOYO-1-labeled pDNA, and (C) unlabeled PAH-coated
microbubbles (50 íL) incubated with 1 íg of YOYO-1-labeled
pDNA. (D) Transmission image corresponding to image C.
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localization of pDNA and PAH. Between the microbubbles in
Figure 6B, some green fluorescence (i.e., unbound pDNA) is
still detected. This could be expected because the maximal pDNA
loading capacity of the microbubbles was exceeded (see below).
When the microbubbles (in this experiment, unlabeled) were
incubated with lower amounts of YOYO-1-labeled pDNA, green
fluorescence between the microbubbles was no longer observed
(Figure 6C).
Successful loading of the PAH-coated microbubbles with
pDNA could also be observed from zeta potential measurements
because the addition of pDNA turned the zeta potential of the
PAH-coated microbubbles negative (Figure 3). This most likely
indicates that pDNA is bound to the surface of the PAH-coated
microbubbles. In contrast, the addition of pDNA to the uncoated
albumin microbubbles did not drastically alter the zeta potential
of the uncoated microbubbles (Figure 3), which is in line with
the observations above. Previously, Porter et al. reported that
oligonucleotides do bind to albumin microbubbles. However,
these authors used phosphorothioate-modified oligonucleotides,
which are known to interact nonspecifically with proteins.30
To estimate the maximal pDNA binding capacity of the PAH-
coated microbubbles, they were incubated (for 5 min) with
increasing amounts of pDNA, and the amount of unbound (i.e.,
free) pDNA in the subnatants (obtained after centrifugation) was
determined via both the PicoGreen assay and FCS. Both tests
revealed that 50 íL of the PAH-coated microbubble dispersion
could maximally bind 1 íg of pDNA (data not shown). Taking
into account that 50 íL of microbubble dispersion contains about
9.95  106 microbubbles, one can estimate that the PAH coating
of the microbubbles enables them to carry 0.1 pg of pDNA or
about 20 000 pDNA molecules per microbubble. These experi-
ments prove that coating the microbubbles with PAH enables a
very efficient loading of albumin microbubbles with plasmid
DNA. As mentioned above, pDNA-loaded microbubbles have
also been developed by other groups. Christiansen et al. and
Vannan et al. prepared cationic microbubbles using lipids as a
shell-forming material.14,12 Compared to PAH-coated mi-
crobubbles, these microbubbles have a 2.5-fold lower pDNA
loading capacity. However, we should take into account that in
their studies the average microbubble size was smaller, which
automatically implies a lower DNA loading. Also, cationic lipid-
based microbubbles are probably more expensive. Frenkel et al.
showed that the sonication of a solution of dextrose, albumin,
and pDNA with perfluoropropane gas leads to microbubbles
that contain albumin and pDNA in their shell.31 However, a
major drawback of this technique is that only a small fraction
of the pDNA seems to become incorporated into the shell.
3.4. Ultrasound Responsiveness and DNase Protection.
Microbubbles enhance the efficiency of ultrasound-assisted gene
delivery as they generate microjets that, upon implosion,
temporarily perforate the cell membranes.14-18 Given the
importance of cavitation, the ultrasound responsiveness of the
uncoated and pDNA-loaded PAH-coated microbubbles was
studied by exposing them for 30 s to ultrasound energy (1 MHz,
1 W/cm2, 50% duty cycle). After ultrasound radiation, 99 and
95% of the uncoated and PAH-coated microbubbles, respectively,
were destroyed, which is in agreement with previous reports.9,20
Despite their higher stability (Figure 5), PAH-coated mi-
crobubbles are thus clearly ultrasound-responsive.
Subsequently, the ability of the microbubbles to protect pDNA
against nucleases was tested using gel electrophoresis. As
described in the Materials and Methods section, the microbubble
dispersions were exposed to 200 U/L rhDNase-I, which is about
20-fold higher than the DNase activity found in human blood.32
Figure 7 shows the gel electrophoresis results on pDNA released
from pDNA-loaded microbubbles (by NaCl) that were exposed
to DNase-I. As shown in Figure 7A, DNase-I degrades both free
pDNA (lane 3) and pDNA in the presence of uncoated
microbubbles (lane 6). In contrast, the pDNA on PAH-coated
microbubbles remains mainly protected (Figure 7B) because only
a very small part of degraded pDNA seems to be present (arrow
in lane 6). The latter can be explained by the fact that in this
experiment a small amount of the pDNA remained in the solution
as the maximal loading capacity of the microbubbles was
exceeded. Clearly, in Figure 7B (lanes 5-7) a part of the pDNA
remained in the slots of the agarose gel. Most presumably, this
is attributed to the fact that, besides free pDNA, (high molecular
weight) pDNA-PAH complexes were also liberated from the
microbubbles upon adding NaCl. This implies that the electrostatic
binding between DNA and PAH is stronger than the interaction
between the albumin and PAH. Thus, a second advantage of the
PAH-coated microbubbles compared to the microbubbles of
Frenkel’s group is that they also protect DNA against DNase-I
degradation.
From Figure 7B (lanes 2 and 5), we can also conclude that
no conformational change of the pDNA occurred upon binding
(24) De Geest, B. G.; Dejugnat, C.; Sukhorukov, G. B.; Braeckmans, K.; De
Smedt, S. C.; Demeester, J. AdV. Mater. 2005, 17, 2357.
(25) Park, M. K.; Deng, S. X.; Advincula, R. C. Langmuir 2005, 21, 5272.
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Figure 7. Gel electrophoresis of pDNA present in an uncoated and
PAH-coated microbubble dispersion with or without DNase-I,
respectively. The data obtained with uncoated microbubbles are
shown by gel A, and those with PAH-coated microbubbles, by gel
B. Each lane contains 1 íg of pDNA. Lane 1, DNA molecular
weight marker; lane 2, free pDNA; lane 3, free pDNA incubated
with rhDNase-I; lane 4, free pDNA incubated with inhibited DNase-
I; lane 5, microbubbles and pDNA; lane 6, microbubbles and pDNA
incubated with DNase-I; lane 7, microbubbles and pDNA incubated
with inhibited DNase-I. Smiling appeared because of the high salt
concentrations used (5 M NaCl).
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to the microbubbles. Indeed, the released DNA (lane 5) is visible
at the same height on the gel as the free pDNA (lane 2).
4. Conclusions
A major issue in ultrasound-assisted gene transfer is the
development of microbubbles that both bind and protect pDNA
against circulating DNases in the bloodstream. It is well known
that binding pDNA with cationic polymers or lipids protects the
pDNA against degradation by DNase I.1 Therefore, we evaluated
the possibility of coating the medically used albumin/perfluo-
rocarbon contrast agents with a cationic polymer. A successful
coating of the albumin-shelled perfluorocarbon microbubbles
with PAH was evidenced from CLSM and zeta potential
measurements. The positive charges on the surface of the PAH-
coated microbubbles allowed the binding of up to 0.1 pg of
pDNA on the wall of a single microbubble. The pDNA bound
on PAH-coated microbubbles was clearly protected against
nucleases. The presence of pDNA on the microbubble may also
enhance the number of pDNA molecules that can enter a cell
during sonoporation. Indeed, small pores (up to 100 nm large)
created by imploding microbubbles have a very short lifetime
(millisecond range).16 To increase the number of pDNA molecules
that pass through these quickly closing pores, it seems clear that
it is important to co-localize DNA and pore-forming mi-
crobubbles. Furthermore, PAH coating of the microbubbles
improved their stability, thereby increasing their (average) lifetime
from 75 min to 6 h while they remained ultrasound-responsive.
Their longer lifetime makes them more convenient for in vivo
therapy because more microbubbles are expected to reach the
target organ. In this study, we used PAH as a cationic polymer
to coat the microbubbles. This polymer is not suitable for in vivo
applications because, as a result of its high molecular weight and
nonbiodegradability, it will not be efficiently cleared from the
human body. However, it is obvious that other cationic polymers
that are more biocompatible and biodegradable may also be used
as coating material. Also, coating microbubbles with cationic
polymers may be an attractive strategy to promote the targeting
of microbubbles because it is rather straightforward to attach
targeting ligands to the polymer coating. This could further
enhance the site-specific delivery of pDNA and could provide
an even higher pDNA concentration close to cell membrane
perforations.33 However, to obtain good gene transfer it is also
important that the pDNA dissociates from the microbubble upon
ultrasound exposure. In our future work, we will tackle this issue
and perform transfection experiments with our microbubbles.
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